- The key vendors in the global cardiac rhythm management devices market 2015-2019 are Boston Scientific, Medtronic and St. Jude Medical
London, 05 August 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global cardiac rhythm management devices market 2015-2019. Growing popularity of robot-assistance surgery is one of the key trends upcoming in the market. Robotic technology provides physicians with an excellent view of the operative field and the ability to maneuver instruments within close-fitting spaces with precision and control. The global cardiac rhythm management devices market 2015-2019 is expected to grow at a CAGR of 1.08% during the forecast period of 2014-2019.
New generation technologies such as energy-harvesting generators and leadless pacemakers are contributing to the market. Rate-adaptive therapy and remote home monitoring have improved healthcare standards. Developments in adjunctive therapy such as the use of non-stimulant drugs, which resume normal heart rhythms, have improved patient outcomes in parallel with CRM therapies.
“The increased prevalence of cardiovascular diseases, caused by changing lifestyles in emerging economies such as China and India, has resulted in high demand for cardiac rhythm management in APAC,” says Faisal Ghaus, Vice President of Technavio Research.
“Many healthcare organizations in the region offer affordable treatments. As a result, global vendors such as Philips Healthcare and Zoll Medical are increasingly focusing on APAC to increase their market share.”
To define the market conditions in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
